Fox Business - The Power to Prosper
Search Site

Alcon

Market check: GOOGL, YHOO, INTC

FBN’s Stuart Varney with the latest business headlines.

Read More

  1. Nestle to Buy Pfizer's Infant Nutrition Unit for $11.9B

    Nestle snatched Pfizer's (NYSE:PFE) infant nutrition business on Monday for nearly $12 billion, making the Swiss food group the largest player in the key Asia-Pacifi...

  2. UK Regulator Changes Stance On Novartis's Gilenya

    LONDON -- Novartis AG's (NVS) multiple sclerosis pill Gilenya has been recommended for use on the U.K.'s publicly funded National Health Service, a welcome decision ...

  3. Novartis Gets Rights To Sell New Eye Drug Outside US

    Novartis (NVS) said Friday it acquired the rights to an experimental eye treatment from ThromboGenics (THR.BT) of Belgium to sell it outside the U.S., in a deal that...

  4. Nestle Ready For Tough 2012 As Earnings Drop

    VEVEY, Switzerland -( Dow Jones )- Nestle SA (NESN.VX) Thursday maintained its growth targets despite expectations of a tough year ahead as it reported a drop in net...

  5. Nestle Expects Tough 2012 As Earnings Drop

    VEVEY, Switzerland -( Dow Jones )- Nestle SA (NESN.VX) Thursday maintained its growth targets despite expectations of a tough year ahead as it reported a drop in net...

  6. Novartis Says Profitability To Decline In 2012

    Switzerland's Novartis AG (NVS) Wednesday said its profitability will decline this year due to competition from generic rivals, continued drug price cuts and the nee...

  7. Novartis Cautious On Outlook As Profit Plunges

    Switzerland's Novartis AG (NVS) Wednesday issued a cautious earnings outlook for 2012 as it reported a 46% drop in fourth-quarter net profit, hit by restructuring co...

  8. EARNINGS PREVIEW: New Drugs, FX Key For Europe Pharma Earnings

    TAKING THE PULSE: European pharmaceutical companies are expected to give mixed performances when announcing fourth-quarter results this month and next, with some mor...

  9. Novartis unit Alcon faces U.S. health fraud probe

    Novartis's <NOVN.VX> recently acquired eyecare business Alcon is facing a U.S. government investigation into alleged healthcare fraud, the Swiss drugmaker said on Tu...

  10. Nestle buys 60 percent of Chinese candy maker for $1.7 billion

    By Saeed Azhar and Lee Chyen YeeSINGAPORE/HONG KONG (Reuters) - Nestle <NESN.VX>, the world's largest food company, offered to buy 60 percent of Chinese candies and ...

  11. Candy maker in talks Nestle, deal could be worth over $2 billion

    By Lee Chyen Yee and Silke KoltrowitzHONG KONG/ZURICH (Reuters) - Nestle <NESN.VX>, the world's largest food company, is among companies in talks with Chinese candie...

  12. Novartis Lifts 1Q Profit on New Products

    Shares of Novartis (NYSE:NVS) rose more than 3% in morning trade after the company revealed a stronger-than-expected jump in first-quarter revenue, led by recently i...

  1. Novartis CEO Reshapes Firm For 'Brutal' New World

    Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new ...

  2. Entrepreneur sells promise of future investment to pay off debt

    Nailed Kit CEO Rachel Honeth Kim raised $100K from investors to pay off debt and launch a startup company.

  3. Novartis chairman floats idea of business review to appease investors

    Less than two weeks into the job, Novartis AG's new chairman is seeking to appease investors by suggesting the Swiss drugmaker will review some of its underperformin...

  4. Novartis Gets EU Approval For Eye-Care Drug Jetrea

    Novartis AG (NOVN.VX) Monday said its eye-care division Alcon has received European approval for Jetrea, a drug which treats a condition which can lead to damaged vi...

  5. Novartis U.S. Unit Subpoenaed in Marketing Probe

    Swiss drug giant Novartis AG (NVS, NOVN.VX) said its U.S. unit has been subpoenaed as part of a federal investigation into the company's marketing of blood pressure ...

  6. Novartis: U.S. Probing Export of Alcon Products to Iran, Other Trade-Sanction Countries

    U.S. authorities are investigating the export of products made by Novartis AG's (NVS) Alcon eye-care unit to various countries subject to U.S. trade sanctions, inclu...

  7. Novartis Drug Does Well in Trial for Age-Related Eye Disease

    An experimental drug that would eliminate the need for onerous and sometimes risky eye surgery in elderly patients showed promising results in two studies to be publ...

‹ Prev12Next ›
Freebase CC-BY
Source: Alcon on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL